D.E. Shaw & Co’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.15M | Sell |
62,064
-181,427
| -75% | -$15M | ﹤0.01% | 1416 |
|
|
2025
Q1 | $19.7M | Sell |
243,491
-129,936
| -35% | -$10.5M | 0.02% | 689 |
|
|
2024
Q4 | $33.6M | Sell |
373,427
-629,378
| -63% | -$56.7M | 0.02% | 490 |
|
|
2024
Q3 | $99.1M | Buy |
+1,002,805
| New | +$99.1M | 0.09% | 167 |
|
|
2024
Q2 | – | Sell |
-303,111
| Closed | -$28.8M | – | 3503 |
|
|
2024
Q1 | $28.8M | Buy |
+303,111
| New | +$28.8M | 0.02% | 454 |
|
|
2023
Q2 | – | Sell |
-1,103,000
| Closed | -$84.1M | – | 3385 |
|
|
2023
Q1 | $84.1M | Sell |
1,103,000
-183,200
| -14% | -$14M | 0.09% | 167 |
|
|
2022
Q4 | $107M | Buy |
1,286,200
+771,200
| +150% | +$64M | 0.12% | 110 |
|
|
2022
Q3 | $40.9M | Buy |
+515,000
| New | +$40.9M | 0.05% | 307 |
|
|
2021
Q2 | – | Sell |
-14,700
| Closed | -$1.99M | – | 3795 |
|
|
2021
Q1 | $1.99M | Buy |
+14,700
| New | +$1.99M | ﹤0.01% | 1849 |
|
|
2020
Q2 | – | Sell |
-18,690
| Closed | -$1.45M | – | 2856 |
|
|
2020
Q1 | $1.45M | Sell |
18,690
-25,000
| -57% | -$1.94M | ﹤0.01% | 1677 |
|
|
2019
Q4 | $4.16M | Hold |
43,690
| – | – | ﹤0.01% | 1270 |
|
|
2019
Q3 | $3.33M | Buy |
+43,690
| New | +$3.33M | ﹤0.01% | 1338 |
|
|
2017
Q1 | – | Sell |
-10,000
| Closed | -$592K | – | 2636 |
|
|
2016
Q4 | $592K | Buy |
+10,000
| New | +$592K | ﹤0.01% | 1958 |
|
|
2016
Q3 | – | Sell |
-47,700
| Closed | -$2.58M | – | 2679 |
|
|
2016
Q2 | $2.58M | Buy |
+47,700
| New | +$2.58M | ﹤0.01% | 1304 |
|